Repurposed Antibiotic May serve as an Effective COVID-19 Therapeutic for infected mice

Study in mice suggests Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology

Repurposed drugs often have a speedier path to clinical use because they have already been shown to be safe in people

While COVID-19 vaccines reduce hospitalizations and death, they do not control virus transmission

Previous attempts to repurpose medicines to treat COVID-19 patients have been unsuccessful thus far

Additionally, the mice were sacrificed only two days after treatment, so longer-term effects remain unknown

Finally, the relatively low cost of this drug suggests that it is a potential clinical option for treatment of COVID-19

"Antivirals targeting SARS-CoV-2 are sorely needed," adds Dubuisson